SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-19-004742
Filing Date
2019-08-13
Accepted
2019-08-13 17:17:30
Documents
46
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nbio_10q.htm 10-Q 186376
2 CERTIFICATION nbio_ex311.htm EX-31.1 7635
3 CERTIFICATION nbio_ex312.htm EX-31.2 7695
4 CERTIFICATION nbio_ex321.htm EX-32.1 3138
5 CERTIFICATION nbio_ex322.htm EX-32.2 3244
  Complete submission text file 0001477932-19-004742.txt   1630245

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nbio-20190630.xml EX-101.INS 209131
7 XBRL TAXONOMY EXTENSION SCHEMA nbio-20190630.xsd EX-101.SCH 33450
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbio-20190630_lab.xml EX-101.LAB 181928
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nbio-20190630_cal.xml EX-101.CAL 11226
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbio-20190630_pre.xml EX-101.PRE 169701
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nbio-20190630_def.xml EX-101.DEF 94373
Mailing Address 6330 NANCY RIDGE DR. SUITE 105 SAN DIEGO CA 92121
Business Address 6330 NANCY RIDGE DR. SUITE 105 SAN DIEGO CA 92121 612-961-5656
Nascent Biotech Inc. (Filer) CIK: 0001622057 (see all company filings)

IRS No.: 450612715 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-55299 | Film No.: 191021764
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1